Practolol inhibition of some salbutamol-induced metabolic and hormonal responses

Acta Diabetol Lat. 1977 Sep-Dec;14(5-6):257-62. doi: 10.1007/BF02580974.

Abstract

The effect of practolol (a selective beta1-adrenergic receptor blocking agent) on increased blood insulin, sugar, lactate and FFA and decreased blood phosphorus and potassium induced by salbutamol (a primarily beta2-adrenergic stimulant) was studied in 6 normal volunteers. Practolol abolished the rise of lactate and glucose, suggesting that changes in these parameters due to salbutamol are mediated by beta1-receptors. The rise of insulin and the fall of potassium were only partially inhibited, and the possible involvement of the beta2-receptors as well in these 2 cases cannot be ruled out. The decrease of phosphorus and the FFA rise were not affected and thus appear to be primarily dependent on beta2-receptors.

MeSH terms

  • Adult
  • Albuterol / antagonists & inhibitors
  • Albuterol / pharmacology*
  • Blood Glucose* / analysis
  • Fatty Acids, Nonesterified / blood*
  • Female
  • Humans
  • Insulin / blood*
  • Lactates / blood*
  • Male
  • Phosphates / blood*
  • Potassium / blood*
  • Practolol / pharmacology*
  • Receptors, Adrenergic / drug effects*
  • Receptors, Adrenergic, beta / drug effects*

Substances

  • Blood Glucose
  • Fatty Acids, Nonesterified
  • Insulin
  • Lactates
  • Phosphates
  • Receptors, Adrenergic
  • Receptors, Adrenergic, beta
  • Albuterol
  • Potassium
  • Practolol